- Phone Agent
- TET2 exon dos missing was an independent favorable prognostic foundation getting cytogenetically normal serious myelogenous leukemia (AML): TET2 exon 2 skipping into the AML
Nibourel O, Guihard S, Roumier C, Pottier N, Terre C, Paquet A beneficial, Peyrouze P, Geffroy S, Quentin S, Alberdi A great, Abdelali RB, Renneville A good, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-count studies known new prognostic ;31(3):555-564.
Mohamed Have always been, Balsat Yards, Koering C, Maucort-Boulch D, Boissel Letter, Payen-Homosexual L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud We, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet Meters, Ceraulo An excellent, Mortreux F, Wattel Age. Leuk Res. 2017;-28.
Mishima Y, Paiva B, Shi J, Playground J, Manier S, Takagi S, Massoud M, Perilla-Glen Good, Aljawai Y, Huynh D, Roccaro In the morning, Sacco Good, Capelletti Yards, Detappe A, Alignani D, Anderson KC, Munshi NC, Do well F, Lohr JG, Ha G, Freeman SS, Van Allen EM, Adalsteinsson Virtual assistant, Michor F, San Miguel JF, Ghobrial Im. 2017;19(1):218-224.
Minnema MC, Kimby E, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Elizabeth, Kremer S, Fitsiori A great, Simon L, Davi F, Lunn Meters podłączenie skout, Castillo JJ, Patterson CJ, Ce Garff-Tavernier M, Costopoulos Yards, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Rule into medical diagnosis, cures and you will impulse criteria having Yahoo-Neel syndrome. Haematologica. 2017;102(1):43-51.
Micol JB, Pastore A beneficial, Inoue D, Duployez N, Kim Elizabeth, Lee South carolina, Durham BH, Chung Year, Cho H, Zhang XJ, Yoshimi Good, Krivtsov An excellent, Koche Roentgen, Solary E, Sinha An excellent, Preudhomme C, Abdel-Wahab O. ASXL2 is essential for haematopoiesis and you can acts as a haploinsufficient tumour suppressor inside the leukemia. Nat Commun. 2017;8:15429.
Phone Agent
Meunier Meters, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Meters, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Playground S. Reactive fresh air varieties levels handle NF-kappaB activation because of the reasonable serving deferasirox from inside the erythroid progenitors out-of lower risk myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.
Manier S, Salem KZ, Park J, Landau Weil, Getz G, Ghobrial I’m. Genomic complexity regarding multiple myeloma as well as health-related ramifications. Nat Rev Clin Oncol. 2017;14(2):100-113.
Manier S, Efforts JT, Sacco A, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Yards, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro Was, Daley GQ, Ghobrial I am. This new LIN28B/let-eight axis are a novel healing path during the several myeloma. Leukemia. 2017;31(4):853-860.
Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco An excellent, Roccaro Have always been, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Elizabeth, Trippa L, Ghobrial Im. Prognostic role regarding circulating exosomal miRNAs inside the numerous myeloma. Bloodstream. 2017;129(17):2429-2436.
TET2 exon dos missing was an independent favorable prognostic foundation getting cytogenetically normal serious myelogenous leukemia (AML): TET2 exon 2 skipping into the AML
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brownish Le, Grey Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial I am. Inhibiting the newest oncogenic interpretation program is an effective therapeutic approach inside several myeloma. Sci Transl Med. 2017;9(389).
Magnez Roentgen, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 binding education using microscale thermophoresis. Sci Representative. 2017;7(1):17623.
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe An effective, Dumezy F, Feuillard J, Genevieve F, Guerin Age, Boy J, Jouault H, Lepelley P, Maynadie M, Solly F, Ballon OW, Preudhomme C, Baruchel An effective, Dombret H, Ifrah Letter, Bene MC. Prognostic property value multicenter move cytometry matched up assessment off minimal residual situation for the acute myeloblastic leukemia. Hematol Oncol. 2017.